Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05457725

Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging

Much of human interaction is based on trust. Aging has been associated with deficits in trust-related decision making, likely further exacerbated in age-associated neurodegenerative disease (Alzheimer's disease/AD), possibly underlying the dramatically growing public health problem of elder fraud. Optimal trust-related decision making and avoiding exploitation require the ability to learn about the trustworthiness of social partners across multiple interactions, but the role that learning plays in determining age deficits in trust decisions is currently unknown.

Aim: Probe the malleability of the underlying neurocircuitry of trust-learning deficits in aging. This study will utilize real-time fMRI neurofeedback to train older adults in brain activity up-regulation toward enhanced trust-related learning in aging and confirm critical mechanisms of experience-dependent social decisions in aging.

Grant R01AG072658 Aim 3: Test the malleability of trust-learning neurocircuitry toward optimized trust-related decision making in aging.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Florida

Gainesville, Florida, 32611, United States

Location status: Recruiting

Location contact

Dana Arnold

CONTACT

352-273-2141

Natalie Ebner, PhD

PRINCIPAL_INVESTIGATOR

About this study

This study will apply rtfMRI neurofeedback training as an intervention method, to demonstrate that older adults can be trained in volitional brain activity up-regulation, reducing their trust-learning deficits. The study will comprises several MRI sessions including pre-training, training, and post-training scans.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to provide verbal and written informed consent
  • Fluent English speaker
  • At least 8th grade education
  • On stable medication regimen

Exclusion criteria

  • Pregnancy
  • Magnetic resonance imaging contraindications (e.g., certain metallic objects in body, claustrophobia)
  • Current major depression defined as scores >14 on the Beck Depression Inventory-II
  • Impaired scores on the Telephone Interview for Cognitive Status (TICS; cut-off of >30)
  • Current use of medications with significant anticholinergic properties due to potential influence on memory ("memory enhancing"; e.g., Aricept or Namenda)
  • Current use of anticonvulsant, neuroleptic, sedatives, or other medications known to affect cognition
  • Uncorrected visual and hearing impairments
  • Neurologic conditions affecting the brain (e.g., severe stroke, epilepsy, traumatic brain injury with >30-minute loss of consciousness)
  • Impaired scores on a cognitive screening measure, the Montreal Cognitive Assessment (MoCA); for older adults the cutoff will be age and education corrected
  • Unstable medical illness (e.g., metastatic cancer)
  • Significant cardiovascular conditions (e.g., major heart attack)
  • Will not exclude participants who are taking anti-depressant medications. Use of antidepressants (particularly SSRI's) and anxiolytic medications will be recorded and included in post-hoc analyses

Treatment and study plan

Contingent rtfMRI neurofeedback training

Behavioral

Contingent rtfMRI neurofeedback training will follow an alternating up-regulation/rest block design with screen-color cues. Visual feedback about real-time brain activity in the ROI will be provided (e.g., via a thermometer bar). During resting blocks, the thermometer bar remains static.

Non-contingent/sham rtfMRI neurofeedback training

Behavioral

Non-contingent/sham rtfMRI neurofeedback training will follow an alternating up-regulation/rest block design with screen-color cues. Visual feedback about non-contingent/sham brain activity in the ROI will be provided (e.g., via a thermometer bar). During resting blocks, the thermometer bar remains static.

Primary outcomes

  1. Neurofeedback Training Success

    Time frame: at baseline and after training completion about 1 week later

    Increase in BOLD signal in ROI during up-regulation trials administration of computerized learning tasks, with contrasting groups and conditions

  2. Behavioral Benefits

    Time frame: at baseline and after training completion about 1 week later

    Increase in trust-related learning reflected in greater accuracy (e.g., in percent) on trust learning task

Study contacts

Contact information is provided by the study sponsor or research team.

Dana Arnold, M.S.

CONTACT

[email protected]

401-617-6061

Ryan Faulkner

CONTACT

[email protected]

727-771-5247

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Official study title

Characterizing and Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging II

Acronym: DecidingBrain

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jul 14, 2022
Registry last updated
Apr 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.